In conclusion, our data is consistent with SFRP1 being a potential suppressor of canine mammary tumour progression, and has shown that reduced β-catenin membrane localisation is associated with higher tumour grade and metastasis formation in dogs, but that SFRP1 expression is not significantly associated with β-catenin membrane localisation. The gene discussed is SFRP1; the disease is breast cancer.